18-10801447-G-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001378183.1(PIEZO2):c.1201-19C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0634 in 1,495,352 control chromosomes in the GnomAD database, including 3,319 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.056   (  293   hom.,  cov: 33) 
 Exomes 𝑓:  0.064   (  3026   hom.  ) 
Consequence
 PIEZO2
NM_001378183.1 intron
NM_001378183.1 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  3.31  
Publications
5 publications found 
Genes affected
 PIEZO2  (HGNC:26270):  (piezo type mechanosensitive ion channel component 2) The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014] 
PIEZO2 Gene-Disease associations (from GenCC):
- Gordon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- arthrogryposis, distal, with impaired proprioception and touchInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics
- arthrogryposis- oculomotor limitation-electroretinal anomalies syndromeInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- connective tissue disorderInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- Marden-Walker syndromeInheritance: AR, AD Classification: MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48). 
BP6
Variant 18-10801447-G-C is Benign according to our data. Variant chr18-10801447-G-C is described in ClinVar as Benign. ClinVar VariationId is 261496.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0646  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PIEZO2 | NM_001378183.1 | c.1201-19C>G | intron_variant | Intron 9 of 55 | ENST00000674853.1 | NP_001365112.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| PIEZO2 | ENST00000674853.1 | c.1201-19C>G | intron_variant | Intron 9 of 55 | NM_001378183.1 | ENSP00000501957.1 | 
Frequencies
GnomAD3 genomes  0.0562  AC: 8556AN: 152160Hom.:  293  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
8556
AN: 
152160
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0519  AC: 7578AN: 146006 AF XY:  0.0521   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
7578
AN: 
146006
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0643  AC: 86305AN: 1343074Hom.:  3026  Cov.: 30 AF XY:  0.0637  AC XY: 42335AN XY: 664686 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
86305
AN: 
1343074
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
42335
AN XY: 
664686
show subpopulations 
African (AFR) 
 AF: 
AC: 
1375
AN: 
30588
American (AMR) 
 AF: 
AC: 
1547
AN: 
35622
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1266
AN: 
24958
East Asian (EAS) 
 AF: 
AC: 
40
AN: 
35516
South Asian (SAS) 
 AF: 
AC: 
3385
AN: 
78322
European-Finnish (FIN) 
 AF: 
AC: 
2978
AN: 
35210
Middle Eastern (MID) 
 AF: 
AC: 
161
AN: 
5634
European-Non Finnish (NFE) 
 AF: 
AC: 
72230
AN: 
1040482
Other (OTH) 
 AF: 
AC: 
3323
AN: 
56742
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.451 
Heterozygous variant carriers
 0 
 3625 
 7251 
 10876 
 14502 
 18127 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 2712 
 5424 
 8136 
 10848 
 13560 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0562  AC: 8560AN: 152278Hom.:  293  Cov.: 33 AF XY:  0.0566  AC XY: 4213AN XY: 74458 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
8560
AN: 
152278
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
4213
AN XY: 
74458
show subpopulations 
African (AFR) 
 AF: 
AC: 
1918
AN: 
41558
American (AMR) 
 AF: 
AC: 
663
AN: 
15294
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
182
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
23
AN: 
5186
South Asian (SAS) 
 AF: 
AC: 
195
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
932
AN: 
10610
Middle Eastern (MID) 
 AF: 
AC: 
6
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
4506
AN: 
68016
Other (OTH) 
 AF: 
AC: 
126
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 423 
 846 
 1269 
 1692 
 2115 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 96 
 192 
 288 
 384 
 480 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
81
AN: 
3476
ClinVar
Significance: Benign 
Submissions summary: Benign:4 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:3 
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.